TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 86 filers reported holding TRICIDA INC in Q4 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,164 | -88.9% | 151,499 | +660.4% | 0.00% | – |
| Q3 2022 | $209,000 | +8.9% | 19,924 | +0.9% | 0.00% | – |
| Q2 2022 | $192,000 | +93.9% | 19,753 | -7.6% | 0.00% | – |
| Q3 2021 | $99,000 | 0.0% | 21,371 | -6.8% | 0.00% | – |
| Q2 2021 | $99,000 | -55.0% | 22,938 | -44.8% | 0.00% | – |
| Q1 2021 | $220,000 | -63.5% | 41,578 | -51.3% | 0.00% | – |
| Q4 2020 | $602,000 | +38.1% | 85,434 | +77.5% | 0.00% | – |
| Q3 2020 | $436,000 | -32.9% | 48,129 | +103.3% | 0.00% | – |
| Q2 2020 | $650,000 | +62.9% | 23,669 | +30.6% | 0.00% | – |
| Q1 2020 | $399,000 | -77.2% | 18,127 | -60.9% | 0.00% | -100.0% |
| Q4 2019 | $1,749,000 | +338.3% | 46,333 | +258.7% | 0.00% | – |
| Q3 2019 | $399,000 | +6.1% | 12,917 | +35.6% | 0.00% | – |
| Q2 2019 | $376,000 | +3.3% | 9,525 | +1.1% | 0.00% | – |
| Q1 2019 | $364,000 | – | 9,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 7,132,079 | $69,039,000 | 13.60% |
| STONEHILL CAPITAL MANAGEMENT LLC | 1,436,736 | $13,908,000 | 9.25% |
| COMMODORE CAPITAL LP | 2,028,453 | $19,635,000 | 4.15% |
| Tri Locum Partners LP | 731,142 | $7,077,000 | 2.90% |
| GREAT POINT PARTNERS LLC | 1,164,763 | $11,275,000 | 2.70% |
| Frazier Life Sciences Management, L.P. | 2,082,093 | $20,155,000 | 1.90% |
| Orbimed Advisors | 10,280,947 | $99,520,000 | 1.80% |
| Deep Track Capital, LP | 2,732,117 | $26,447,000 | 1.74% |
| Lion Point Capital, LP | 1,826,729 | $12,034,000 | 1.37% |
| Bleichroeder LP | 450,000 | $4,356,000 | 0.90% |